T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Moderna
MRNA
$25.4B
| $522M | 0.05% |
2,222,575
-115,320
| -5% | -$20.6M |
|
327
AXIS Capital
AXS
$7.26B
| $520M | 0.05% |
10,609,559
+170
| +0% | +$9.02K |
|
328
Armstrong World Industries
AWI
$7.75B
| $518M | 0.05% |
4,832,332
-1,088,081
| -18% | -$112M |
|
329
3M
MMM
$94.8B
| $515M | 0.05% |
3,101,881
+539,279
| +21% | +$90M |
|
330
Zebra Technologies
ZBRA
$17.9B
| $514M | 0.05% |
970,525
-11,529
| -1% | -$5.75M |
|
331
PTC
PTC
$16.1B
| $513M | 0.05% |
3,632,224
+1,273,654
| +54% | +$174M |
|
332
Hubbell
HUBB
$27.1B
| $511M | 0.05% |
2,736,942
+313,081
| +13% | +$59.1M |
|
333
Yum China
YUMC
$16.4B
| $506M | 0.05% |
7,638,886
+209,926
| +3% | +$13.4M |
|
334
Align Technology
ALGN
$12.4B
| $506M | 0.05% |
827,934
-730,355
| -47% | -$432M |
|
335
Pinnacle Financial Partners Inc
PNFP
$16.1B
| $503M | 0.05% |
5,695,363
+50,236
| +0.9% | +$4.49M |
|
336
Pinduoduo
PDD
$127B
| $500M | 0.05% |
3,934,698
-1,418,245
| -26% | -$184M |
|
337
Flowers Foods
FLO
$1.52B
| $499M | 0.05% |
20,616,014
+881,512
| +4% | +$21.4M |
|
338
Halliburton
HAL
$27.7B
| $491M | 0.05% |
21,236,482
-2,801,091
| -12% | -$62.2M |
|
339
Neurocrine Biosciences
NBIX
$15.9B
| $489M | 0.05% |
5,029,259
-744,100
| -13% | -$71.3M |
|
340
ICU Medical
ICUI
$4.48B
| $489M | 0.05% |
2,376,620
-201,200
| -8% | -$41.4M |
|
341
Ionis Pharmaceuticals
IONS
$9.39B
| $489M | 0.05% |
12,258,827
-321,229
| -3% | -$12.6M |
|
342
Equity Lifestyle Properties
ELS
$12.4B
| $486M | 0.05% |
6,545,730
+2,417,572
| +59% | +$171M |
|
|
SRCL
343
DELISTED
Stericycle Inc
SRCL
| $485M | 0.04% |
6,775,497
+249,209
| +4% | +$18.3M |
|
344
Raymond James Financial
RJF
$34.9B
| $482M | 0.04% |
5,568,176
-1,025,893
| -16% | -$89.3M |
|
345
RenaissanceRe
RNR
$13.2B
| $482M | 0.04% |
3,237,063
+2,287,848
| +241% | +$364M |
|
346
Adobe
ADBE
$103B
| $479M | 0.04% |
817,589
-12,145
| -1% | -$6.26M |
|
347
Vulcan Materials
VMC
$36.3B
| $476M | 0.04% |
2,733,522
+1,321,005
| +94% | +$236M |
|
348
Euronet Worldwide
EEFT
$2.66B
| $474M | 0.04% |
3,504,611
+778,625
| +29% | +$113M |
|
349
Alexandria Real Estate Equities
ARE
$8.27B
| $465M | 0.04% |
2,554,329
+1,070,159
| +72% | +$192M |
|
350
Lowe's Companies
LOW
$121B
| $465M | 0.04% |
2,394,949
-680,144
| -22% | -$133M |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.